Clinical Summary: KCNx Database

The KCNx Database is a tool specialized in the KCNx family of potassium channels, essential for the diagnosis and management of congenital neurological disorders in childhood.

Objective and Clinical Application

  • Facilitates the differential diagnosis of early epilepsies, ataxias and developmental disorders.
  • Enables functional interpretation of genetic variants in K⁺ channels using tissue expression data and impact prediction.
  • Integrates prediction algorithms (CADD, REVEL, PolyPhen-2) to evaluate pathogenicity.

Main Associated Syndromes

  • KCN1 (Kv1.1): Episodic ataxia and paralysis syndrome type 1 (EA1). Phenotype: intermittent ataxia, tremors, partial seizures. Mutations in S6 domain → reduction of K⁺ current.
  • KCN2 (Kv2.1): Neonatal epilepsy with severe hypotonia, progressive encephalopathy and cardiac anomalies (associated Brugada syndrome).
  • KCN13 (Kv13): Associated with dysfunction in intracellular potassium homeostasis during brain development.
Diagrama de flujo que muestra las principales categorías de información contenidas en el KCNx database: genética, estructura y funciones.
Figure 1. Flow diagram that organizes the information from the KCNx Database into three essential axes: genetics, molecular structure and physiological functions of the KCNx channels. It allows a multidimensional evaluation of variants, key for differential diagnosis and therapeutic selection.

The integration of fetal tissue expression data allows predicting the impact of a mutation on specific stages of brain development.

Clinical Use and Limitations

  • Allows interactive therapeutic guidance: e.g. acetazolamide or lamotrigine to stabilize membrane in EA1.
  • Limitations: does not include all described phenotypes; Functional predictions require experimental validation.

Access: KCNx Database – Neuropedia Toolkit